Report Detail

Other Global Artemisinin Combination Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • RnM3861174
  • |
  • 30 December, 2019
  • |
  • Global
  • |
  • 107 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Description

Scope of the Report:
The global Artemisinin Combination Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Artemisinin Combination Therapy.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Artemisinin Combination Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Artemisinin Combination Therapy market by product type and applications/end industries.

Market Segment by Companies, this report covers
KPC Pharmaceuticals
Denk Pharma
Desano Holdings
Shanghai Fosun Pharmaceutical Industrial Development
Novartis
Sanofi
Ipca Laboratories
Mylan
Calyx Chemicals and Pharmaceuticals
Hovid Berhad
Cipla
Guilin Pharmaceuticals
Aspen Pharmacare Holdings
Ajanta Pharma

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Artemether+Lumefantrine
Artesunate+Amodiaquine
Dihydroartemisinin+Piperaquine
Artesunate+Mefloquine
Artesunate+Sulfadoxine-Pyrimethamine
Pyronaridine-Artesunate
Other

Market Segment by Applications, can be divided into
Hospital
Clinic
Other


Table of Contents

    1 Artemisinin Combination Therapy Market Overview

    • 1.1 Product Overview and Scope of Artemisinin Combination Therapy
    • 1.2 Classification of Artemisinin Combination Therapy by Types
      • 1.2.1 Global Artemisinin Combination Therapy Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Artemisinin Combination Therapy Revenue Market Share by Types in 2018
      • 1.2.3 Artemether+Lumefantrine
      • 1.2.4 Artesunate+Amodiaquine
      • 1.2.5 Dihydroartemisinin+Piperaquine
      • 1.2.6 Artesunate+Mefloquine
      • 1.2.7 Artesunate+Sulfadoxine-Pyrimethamine
      • 1.2.8 Pyronaridine-Artesunate
      • 1.2.9 Other
    • 1.3 Global Artemisinin Combination Therapy Market by Application
      • 1.3.1 Global Artemisinin Combination Therapy Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Hospital
      • 1.3.3 Clinic
      • 1.3.4 Other
    • 1.4 Global Artemisinin Combination Therapy Market by Regions
      • 1.4.1 Global Artemisinin Combination Therapy Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Artemisinin Combination Therapy Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Artemisinin Combination Therapy Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Artemisinin Combination Therapy Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Artemisinin Combination Therapy Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Artemisinin Combination Therapy Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Artemisinin Combination Therapy (2014-2024)

    2 Company Profiles

    • 2.1 KPC Pharmaceuticals
      • 2.1.1 Business Overview
      • 2.1.2 Artemisinin Combination Therapy Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 KPC Pharmaceuticals Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Denk Pharma
      • 2.2.1 Business Overview
      • 2.2.2 Artemisinin Combination Therapy Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Denk Pharma Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Desano Holdings
      • 2.3.1 Business Overview
      • 2.3.2 Artemisinin Combination Therapy Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Desano Holdings Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Shanghai Fosun Pharmaceutical Industrial Development
      • 2.4.1 Business Overview
      • 2.4.2 Artemisinin Combination Therapy Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Novartis
      • 2.5.1 Business Overview
      • 2.5.2 Artemisinin Combination Therapy Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Novartis Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Sanofi
      • 2.6.1 Business Overview
      • 2.6.2 Artemisinin Combination Therapy Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Sanofi Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Ipca Laboratories
      • 2.7.1 Business Overview
      • 2.7.2 Artemisinin Combination Therapy Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Ipca Laboratories Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Mylan
      • 2.8.1 Business Overview
      • 2.8.2 Artemisinin Combination Therapy Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Mylan Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Calyx Chemicals and Pharmaceuticals
      • 2.9.1 Business Overview
      • 2.9.2 Artemisinin Combination Therapy Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Hovid Berhad
      • 2.10.1 Business Overview
      • 2.10.2 Artemisinin Combination Therapy Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Hovid Berhad Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Cipla
      • 2.11.1 Business Overview
      • 2.11.2 Artemisinin Combination Therapy Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Cipla Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Guilin Pharmaceuticals
      • 2.12.1 Business Overview
      • 2.12.2 Artemisinin Combination Therapy Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Guilin Pharmaceuticals Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Aspen Pharmacare Holdings
      • 2.13.1 Business Overview
      • 2.13.2 Artemisinin Combination Therapy Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Aspen Pharmacare Holdings Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Ajanta Pharma
      • 2.14.1 Business Overview
      • 2.14.2 Artemisinin Combination Therapy Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Ajanta Pharma Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Artemisinin Combination Therapy Market Competition, by Players

    • 3.1 Global Artemisinin Combination Therapy Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Artemisinin Combination Therapy Players Market Share
      • 3.2.2 Top 10 Artemisinin Combination Therapy Players Market Share
    • 3.3 Market Competition Trend

    4 Global Artemisinin Combination Therapy Market Size by Regions

    • 4.1 Global Artemisinin Combination Therapy Revenue and Market Share by Regions
    • 4.2 North America Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
    • 4.5 South America Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)

    5 North America Artemisinin Combination Therapy Revenue by Countries

    • 5.1 North America Artemisinin Combination Therapy Revenue by Countries (2014-2019)
    • 5.2 USA Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)

    6 Europe Artemisinin Combination Therapy Revenue by Countries

    • 6.1 Europe Artemisinin Combination Therapy Revenue by Countries (2014-2019)
    • 6.2 Germany Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
    • 6.3 UK Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
    • 6.4 France Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Artemisinin Combination Therapy Revenue by Countries

    • 7.1 Asia-Pacific Artemisinin Combination Therapy Revenue by Countries (2014-2019)
    • 7.2 China Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
    • 7.5 India Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)

    8 South America Artemisinin Combination Therapy Revenue by Countries

    • 8.1 South America Artemisinin Combination Therapy Revenue by Countries (2014-2019)
    • 8.2 Brazil Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Artemisinin Combination Therapy by Countries

    • 9.1 Middle East and Africa Artemisinin Combination Therapy Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)

    10 Global Artemisinin Combination Therapy Market Segment by Type

    • 10.1 Global Artemisinin Combination Therapy Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Artemisinin Combination Therapy Market Forecast by Type (2019-2024)
    • 10.3 Artemether+Lumefantrine Revenue Growth Rate (2014-2024)
    • 10.4 Artesunate+Amodiaquine Revenue Growth Rate (2014-2024)
    • 10.5 Dihydroartemisinin+Piperaquine Revenue Growth Rate (2014-2024)
    • 10.6 Artesunate+Mefloquine Revenue Growth Rate (2014-2024)
    • 10.7 Artesunate+Sulfadoxine-Pyrimethamine Revenue Growth Rate (2014-2024)
    • 10.8 Pyronaridine-Artesunate Revenue Growth Rate (2014-2024)
    • 10.9 Other Revenue Growth Rate (2014-2024)

    11 Global Artemisinin Combination Therapy Market Segment by Application

    • 11.1 Global Artemisinin Combination Therapy Revenue Market Share by Application (2014-2019)
    • 11.2 Artemisinin Combination Therapy Market Forecast by Application (2019-2024)
    • 11.3 Hospital Revenue Growth (2014-2019)
    • 11.4 Clinic Revenue Growth (2014-2019)
    • 11.5 Other Revenue Growth (2014-2019)

    12 Global Artemisinin Combination Therapy Market Size Forecast (2019-2024)

    • 12.1 Global Artemisinin Combination Therapy Market Size Forecast (2019-2024)
    • 12.2 Global Artemisinin Combination Therapy Market Forecast by Regions (2019-2024)
    • 12.3 North America Artemisinin Combination Therapy Revenue Market Forecast (2019-2024)
    • 12.4 Europe Artemisinin Combination Therapy Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Artemisinin Combination Therapy Revenue Market Forecast (2019-2024)
    • 12.6 South America Artemisinin Combination Therapy Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Artemisinin Combination Therapy Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Summary:
      Get latest Market Research Reports on Artemisinin Combination Therapy. Industry analysis & Market Report on Artemisinin Combination Therapy is a syndicated market report, published as Global Artemisinin Combination Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Artemisinin Combination Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,756.16
      4,134.24
      5,512.32
      3,215.52
      4,823.28
      6,431.04
      526,489.20
      789,733.80
      1,052,978.40
      290,127.60
      435,191.40
      580,255.20
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report